Vimarsana
Biggest News Aggregation in the World

Page 4 - Antipsychotics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antipsychotics Today - Breaking & Trending Today

Long-Acting Injectables Curb Schizophrenia Readmission - Vimarsana News

Long-Acting Injectables Curb Schizophrenia Readmission

Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic.

Gut Signature for Treatment-Resistant Schizophrenia? - Vimarsana News

Gut Signature for Treatment-Resistant Schizophrenia?

Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.

The Solution to a 'Common and Hazardous' Symptom of BPD? - Vimarsana News

The Solution to a 'Common and Hazardous' Symptom of BPD?

Recent research highlighted the potential role of an atypical antipsychotic to treat anxiety — a prevalent and undertreated symptom in BPD that comes without the typical metabolic side effects.

Schizophrenia Med Safe, Effective for Bipolar Mania - Vimarsana News

Schizophrenia Med Safe, Effective for Bipolar Mania

Iloperidone, an atypical antipsychotic approved for schizophrenia, appears to be safe and effective in the treatment of bipolar mania, phase 3 results of an RCT showed.

Positive Phase 3 Results for New Antipsychotic in Psychosis - Vimarsana News

Positive Phase 3 Results for New Antipsychotic in Psychosis

The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal EMERGENT-2 trial.